Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.385 USD | +2.98% | +3.21% | +27.33% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.33% | 759M | |
+17.01% | 124B | |
+16.42% | 109B | |
-6.70% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-7.40% | 16.61B | |
-37.63% | 16.43B | |
+2.22% | 13.4B | |
+24.28% | 11.47B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- WAVE Life Sciences Kicks off $100 Million Offering; Shares Plunge in Premarket Activity